The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...
In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...
(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...
New federal reports value a massive investment portfolio of stocks, bonds and mutual funds managed on behalf of The Church of ...
The stock has also performed well this year, rising roughly 36% (as of Nov. 14), ahead of the broader market. Given that Eli ...
Medpage Today on MSN23h
Tirzepatide Officially Puts GLP-1 Meds on the Map for Obesity-Related Heart FailureCHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and ...
The UK medicines regulator approved Eli Lilly's Alzheimer's disease therapy Kisunla today, but the drug is too expensive to be funded by the NHS, according to cost-effectiveness watchdog NICE.
Eli Lilly has agreed a deal to acquire French antibody-drug conjugate (ADC) specialist Mablink, continuing a series of transactions that build its position in what has become one of the fastest ...
BOTTOM LINE: Brown plays Sacred Heart after Kino Lilly Jr. scored 24 points in Brown’s 73-65 loss to the Holy Cross Crusaders. Brown finished 13-18 overall last season while going 5-7 at home. The ...
Kino Lilly Jr. became the program leader for most three-pointers made as the Brown men’s basketball team fell to Holy Cross, ...
Prime Minister Narendra Modi arrived in Nigeria on Sunday, marking the first visit by an Indian Prime Minister in 17 years. He will receive the Grand Commander of the Order of the Niger (GCON ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback